FundedIQ
Biopharma

Neurosterix: Funding, Investors & Team (Nov 2026)

Neurosterix develops pharmaceutical compounds and drug discovery programs focused on treating neuropsychiatric and neurological disorders.

www.neurosterix.com LinkedIn Geneva, Switzerland 11-50 employees Founded 2024
Total raised
$105M
Rounds
1
Latest
Series B
Nov 2026

Neurosterix has raised $105M across 1 funding round on record, the most recent a Series B of $105M announced in Nov 2026.

That round is above the $3.8M median round size for Switzerland companies tracked on FundedIQ over the last two years.

Neurosterix Company Profile and Key Stats

Total funding raised
$105M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$105M in Nov 2026
Employees
11-50
reported band
Founded
2024
Headquarters
Geneva, Switzerland
Investors on record
10
5 named below

Latest funding round on record: Nov 2026.

Neurosterix Funding Rounds

Date
Round
Amount
Series B
$105M

Neurosterix Investors

Perceptive Advisors RTW Investments Janus Henderson Investors Affinity Asset Advisors Google Ventures

10 investors are recorded in total; the 5 named above are those the record identifies.

Neurosterix Founders and Leadership Team

Name
Role
Contact
Lisa Corey
Vice President, Clinical Operations
Locked
Ted Keysor
COO
Locked

Contact details for the Neurosterix team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Neurosterix Funding in Context

Segment
Companies
Median round
898
$3.8M
4,483
$32M

Neurosterix's latest round of $105M is above the median round in Switzerland. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Neurosterix in Biopharma and Geneva

Companies Similar to Neurosterix

Neurosterix Funding FAQs

What does Neurosterix do?

Neurosterix develops pharmaceutical compounds and drug discovery programs focused on treating neuropsychiatric and neurological disorders.

How much funding has Neurosterix raised?

Neurosterix has raised $105M across 1 round on record. The most recent is a Series B of $105M announced in Nov 2026.

When did Neurosterix last raise funding?

Neurosterix's most recent funding round on record is a Series B of $105M, announced in Nov 2026.

Who has invested in Neurosterix?

Investors on record for Neurosterix include Perceptive Advisors, RTW Investments, Janus Henderson Investors, Affinity Asset Advisors, Google Ventures. FundedIQ records 10 investors in total.

Where is Neurosterix headquartered?

Neurosterix is based in Geneva, Switzerland.

How many employees does Neurosterix have?

Neurosterix is in the 11-50 employee band.

When was Neurosterix founded?

Neurosterix was founded in 2024.

About FundedIQ's Neurosterix Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurosterix is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.